119 related articles for article (PubMed ID: 35180548)
21. Identification of a nomogram based on an 8-lncRNA signature as a novel diagnostic biomarker for head and neck squamous cell carcinoma.
Mao R; Chen Y; Xiong L; Liu Y; Zhang T
Aging (Albany NY); 2020 Oct; 12(20):20778-20800. PubMed ID: 33091878
[TBL] [Abstract][Full Text] [Related]
22. Development and Validation of a Nomogram-Based Prognostic Evaluation Model for Sarcomatoid Hepatocellular Carcinoma.
Ge D; Luo Z; Mao R; Zhao H; Lv X; Zhao J; Zhou J; Huang Z; Zhang Y; Li Z; Bi X; Cai J
Adv Ther; 2020 Jul; 37(7):3185-3205. PubMed ID: 32436026
[TBL] [Abstract][Full Text] [Related]
23. A novel seven-gene signature as Prognostic Biomarker in Hepatocellular Carcinoma.
Xie H; Liu S; Zhang Z; Chen P; Tao Y
J Cancer; 2020; 11(19):5768-5781. PubMed ID: 32913470
[TBL] [Abstract][Full Text] [Related]
24. Development and validation of epithelial mesenchymal transition-related prognostic model for hepatocellular carcinoma.
Wang X; Xing Z; Xu H; Yang H; Xing T
Aging (Albany NY); 2021 Apr; 13(10):13822-13845. PubMed ID: 33929972
[TBL] [Abstract][Full Text] [Related]
25. Identification of five long noncoding RNAs signature and risk score for prognosis of bladder urothelial carcinoma.
Zhang C; Li Z; Hu J; Qi F; Li X; Luo J
J Cell Biochem; 2020 Jan; 121(1):856-866. PubMed ID: 31373406
[TBL] [Abstract][Full Text] [Related]
26. Development of a prognostic gene signature for hepatocellular carcinoma.
Wu C; Luo Y; Chen Y; Qu H; Zheng L; Yao J
Cancer Treat Res Commun; 2022; 31():100511. PubMed ID: 35030478
[TBL] [Abstract][Full Text] [Related]
27. Identification of a Five-Gene Signature and Establishment of a Prognostic Nomogram to Predict Progression-Free Interval of Papillary Thyroid Carcinoma.
Wu M; Yuan H; Li X; Liao Q; Liu Z
Front Endocrinol (Lausanne); 2019; 10():790. PubMed ID: 31803141
[No Abstract] [Full Text] [Related]
28. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W
Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777
[TBL] [Abstract][Full Text] [Related]
29. Development and validation of a robust epithelial-mesenchymal transition (EMT)-related prognostic signature for hepatocellular carcinoma.
Chen S; Zhao E
Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101587. PubMed ID: 33662631
[TBL] [Abstract][Full Text] [Related]
30. Identification and external validation of a prognostic signature associated with DNA repair genes in gastric cancer.
Chen S; Liu W; Huang Y
Sci Rep; 2021 Mar; 11(1):7141. PubMed ID: 33785812
[TBL] [Abstract][Full Text] [Related]
31. Nomogram based on autophagy related genes for predicting the survival in melanoma.
Deng G; Wang W; Li Y; Sun H; Chen X; Zeng F
BMC Cancer; 2021 Nov; 21(1):1258. PubMed ID: 34809598
[TBL] [Abstract][Full Text] [Related]
32. Identification of a 6-lncRNA prognostic signature based on microarray re-annotation in gastric cancer.
Ma B; Li Y; Ren Y
Cancer Med; 2020 Jan; 9(1):335-349. PubMed ID: 31743579
[TBL] [Abstract][Full Text] [Related]
33. Establishing a cancer driver gene signature-based risk model for predicting the prognoses of gastric cancer patients.
Chen J; Zhou C; Liu Y
Aging (Albany NY); 2022 Mar; 14(5):2383-2399. PubMed ID: 35288483
[TBL] [Abstract][Full Text] [Related]
34. An Integrated Model Based on a Six-Gene Signature Predicts Overall Survival in Patients With Hepatocellular Carcinoma.
Li W; Lu J; Ma Z; Zhao J; Liu J
Front Genet; 2019; 10():1323. PubMed ID: 32010188
[No Abstract] [Full Text] [Related]
35. Development of a macrophages-related 4-gene signature and nomogram for the overall survival prediction of hepatocellular carcinoma based on WGCNA and LASSO algorithm.
Yang Z; Zi Q; Xu K; Wang C; Chi Q
Int Immunopharmacol; 2021 Jan; 90():107238. PubMed ID: 33316739
[TBL] [Abstract][Full Text] [Related]
36. Identification of novel antioxidant gene signature to predict the prognosis of patients with gastric cancer.
Wu J; Wang X; Wang N; Ma L; Xie X; Zhang H; Kang H; Zhou Z
World J Surg Oncol; 2021 Jul; 19(1):219. PubMed ID: 34284774
[TBL] [Abstract][Full Text] [Related]
37. Identification of a 6-Gene Signature Associated with Resistance to Tyrosine Kinase Inhibitors: Prognosis for Clear Cell Renal Cell Carcinoma.
Li Q; Yang W; Lu M; Zhang R
Med Sci Monit; 2020 Dec; 26():e927078. PubMed ID: 33296352
[TBL] [Abstract][Full Text] [Related]
38. Development and validation of an immune gene-set based prognostic signature for soft tissue sarcoma.
Shen R; Liu B; Li X; Yu T; Xu K; Ma J
BMC Cancer; 2021 Feb; 21(1):144. PubMed ID: 33557781
[TBL] [Abstract][Full Text] [Related]
39. A novel prognostic signature based on four glycolysis-related genes predicts survival and clinical risk of hepatocellular carcinoma.
Chen Z; Zou Y; Zhang Y; Chen Z; Wu F; Shi N; Jin H
J Clin Lab Anal; 2021 Nov; 35(11):e24005. PubMed ID: 34523732
[TBL] [Abstract][Full Text] [Related]
40. Identification of a novel metabolism-related gene signature associated with the survival of bladder cancer.
Li X; Fu S; Huang Y; Luan T; Wang H; Wang J
BMC Cancer; 2021 Nov; 21(1):1267. PubMed ID: 34819038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
